Panel Discussion: What Is the Role of Medical Affairs in the Launch of a Gene Therapy
Time: 11:10 am
day: Day Two
- How can medical affairs prepare the market for an imminent launch beyond reactive responses?
- How should medical affairs promote the distinctive features of a clinical program?
- How do you keep KOL’s engaged and the gene therapy front of mind in a complaint manner?